Recap: WisdomTree Inv Q2 Earnings

  WisdomTree Inv (NASDAQ:WETF) reported its Q2 earnings results on Friday, July 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings WisdomTree Inv reported in-line EPS of $0.07 versus an estimate of $0.07.

 

WisdomTree Inv (NASDAQ:WETF) reported its Q2 earnings results on Friday, July 29, 2022 at 07:00 AM.

Here’s what investors need to know about the announcement.

Earnings

WisdomTree Inv reported in-line EPS of $0.07 versus an estimate of $0.07.

Revenue was down $350 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 4.43% drop in the share price the next day.

Here’s a look at WisdomTree Inv’s past performance:

 

Quarter Q1 2022 Q4 2021 Q3 2021 Q2 2021
EPS Estimate 0.08 0.08 0.09 0.09
EPS Actual 0.09 0.10 0.10 0.10
Revenue Estimate 78.74M 77.69M 77.70M 74.10M
Revenue Actual 78.37M 79.17M 78.11M 77.60M

To track all earnings releases for WisdomTree Inv visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Viracta Therapeutics Announces Interim Data From Phase 1b/2 Clinical Trial Of Nana-val In Patients With Epstein-Barr Virus-Positive Solid Tumors That Show Confirmed Tumor Responses At Higher Dose Levels

Confirmed partial responses without dose-limiting toxicities during dose escalation along with new preclinical data support the opportunity to further enhance efficacy through a novel split daily dosing regimen at higher

VIRX